NCT06351033View on ClinicalTrials.gov

Ozonized Oil as Dietary Supplement in Macular Degeneration

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Maculopathy
Interventions
DIETARY_SUPPLEMENT

High ozonide (HOO) ozonated oil

ozonated oil with high ozonides (HOO) administered orally (os) in gastro-resistant capsules

Trial Locations (1)

Unknown

IRCCS Neuromed, Pozzilli

All Listed Sponsors
lead

Alba Di Pardo

OTHER

NCT06351033 - Ozonized Oil as Dietary Supplement in Macular Degeneration | Biotech Hunter | Biotech Hunter